Privacy Statement

Overall policy

Privacy is of great concern to Strongbridge Biopharma. We try to extend to our Web site visitors the same level of privacy that we demand from other Web sites. We will not sell, trade, exchange or otherwise make available any personally identifiable information to any other company or organization not directly affiliated with Strongbridge Biopharma.

Traffic analysis

Strongbridge Biopharma uses software programs to analyze traffic to this Web site. These programs collect aggregate data, not personal information.

Email

Strongbridge Biopharma may offer visitors the ability to sign up for e-mail newsletters and announcements. We will never sell your e-mail address or share it with anyone else not directly affiliated with Strongbridge Biopharma.

Cookies

Strongbridge Biopharma uses cookies on this Web site, but only in relation to log analysis, forms completion, and to aid in your ease of use. We do not track individual users.

Forms

Inquiry forms, such as information requests, or site registration, collect information that is securely stored and that will only be used to direct you to the resources you seek. This may include follow up by one of our associates to answer questions you may have.

Links to other sites

The Strongbridge Biopharma Web site contains links to other Web sites & Internet resources. Strongbridge Biopharma is not responsible for the privacy practices or the content of these other Web sites & Internet resources.

EXPAND

Indication and Important Safety Information

What is KEVEYIS?

KEVEYIS (keh-VAY-iss) (dichlorphenamide) is a prescription drug used to treat primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and other similar diseases.

What should you tell your healthcare provider before taking KEVEYIS?

Tell your doctor if you are allergic to dichlorphenamide or other sulfur drugs; if you take high doses of aspirin, or if you have lung or liver disease; if you are pregnant, plan to become pregnant, or are breastfeeding or plan to breastfeed.

What should you know about KEVEYIS?

  • Severe allergic and other reactions have happened with sulfonamides (drugs such as KEVEYIS) and have sometimes been fatal. Stop taking KEVEYIS at the first sign of skin rash, swelling, difficulty breathing, or any other unexpected side effect or reaction, and call 911 right away.
  • Tell your healthcare provider if you take aspirin or if another healthcare provider instructs you to begin taking aspirin. High doses of aspirin should not be taken with KEVEYIS.
  • KEVEYIS can cause your body to lose potassium, which can lead to heart problems. Your healthcare provider will measure the potassium levels in your blood before you start treatment and at certain times during treatment.
  • Tell your healthcare provider about all other prescription and over-the-counter medicines you take, including supplements, as some medicines can interact with KEVEYIS.
  • While taking KEVEYIS, your body may produce too much acid or may not be able to remove acid from the body. Your healthcare provider may run tests on a regular basis to check for signs of acid buildup.
  • KEVEYIS may increase your risk of falling. Tell your healthcare provider right away if you experience a fall while taking KEVEYIS.
  • The risks of falls and acid buildup are greater in elderly patients.
  • It is not known whether KEVEYIS is safe or effective for people younger than 18 years of age.

What are the most common side effects with KEVEYIS?

The most common side effects are a feeling of numbness, tingling or burning (“pins and needles”) in the toes, feet, hands or fingers; trouble with memory or thinking; feeling confused; and unpleasant taste in the mouth.

These are not all of the possible side effects of KEVEYIS. Call your healthcare provider for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch/ or call 1-800-FDA-1088.